Does ALEMTUZUMAB Cause Hyperthyroidism? 236 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 236 reports of Hyperthyroidism have been filed in association with ALEMTUZUMAB (Campath). This represents 1.7% of all adverse event reports for ALEMTUZUMAB.
236
Reports of Hyperthyroidism with ALEMTUZUMAB
1.7%
of all ALEMTUZUMAB reports
0
Deaths
100
Hospitalizations
How Dangerous Is Hyperthyroidism From ALEMTUZUMAB?
Of the 236 reports, 100 (42.4%) required hospitalization, and 5 (2.1%) were considered life-threatening.
Is Hyperthyroidism Listed in the Official Label?
Yes, Hyperthyroidism is listed as a known adverse reaction in the official FDA drug label for ALEMTUZUMAB.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Hyperthyroidism?
LEVOTHYROXINE (1,681)
AMIODARONE (1,410)
NIVOLUMAB (934)
PEMBROLIZUMAB (780)
IPILIMUMAB (525)
CARBOPLATIN (432)
ATEZOLIZUMAB (416)
PACLITAXEL (261)
LENVATINIB (231)
PREDNISONE (220)
Which ALEMTUZUMAB Alternatives Have Lower Hyperthyroidism Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET